Asian Study to Investigate Safety and Efficacy of Optimized Dosing of Advagraf in Kidney Transplantation

NCT02161237 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: Advagraf®

Sponsor

Astellas Pharma Inc